Compare OR & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OR | BRKR |
|---|---|---|
| Founded | 2014 | 1960 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.5B | 5.6B |
| IPO Year | 2014 | 2000 |
| Metric | OR | BRKR |
|---|---|---|
| Price | $42.74 | $36.86 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 13 |
| Target Price | $38.75 | ★ $49.54 |
| AVG Volume (30 Days) | 978.1K | ★ 2.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 0.50% | ★ 0.55% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | $100.08 | $6.27 |
| Revenue Next Year | $13.87 | $3.78 |
| P/E Ratio | $55.77 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.99 | $28.53 |
| 52 Week High | $48.06 | $56.22 |
| Indicator | OR | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 47.64 | 34.77 |
| Support Level | $30.31 | $35.41 |
| Resistance Level | $44.36 | $37.64 |
| Average True Range (ATR) | 1.88 | 1.45 |
| MACD | -0.40 | -0.00 |
| Stochastic Oscillator | 21.01 | 14.49 |
OR Royalties Inc, formerly Osisko Gold Royalties Ltd is engaged in the business of acquiring and managing precious metal and other high-quality royalties, streams and similar interests. The Company owns a portfolio of royalties, streams, offtakes, options on royalty/stream financings and exclusive rights to participate in future royalty/stream financings on various projects. Geographically, it generates majority of its income from North America and also generates some portions of income from South America, Australia, Africa and Europe.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.